Skip to main content

Security report for badaniaklinicznewpolsce.pl

Związek Pracodawców Innowacyjnych Firm Farmaceutycznych INFARMA · Healthcare · Poland

High risk. 11 critical or high findings in GDPR outside view, Network security and 2 other checks.

Security score

40/100

Risk levelHigh

0–100, higher is better. How it is calculated

INFARMA is a Polish employers' union representing innovative pharmaceutical companies, focusing on advancing medical research, clinical trials, and pharmaceutical innovation. The website serves as an information hub for clinical trials, industry collaboration, and patient education, positioning INFARMA as a leading industry association in Poland. The site is professionally designed, well-structured, and provides comprehensive resources and contact information, including multilingual support and social media presence. Technically, the website employs modern web technologies such as Bootstrap, Google Fonts, Google Analytics, and Google reCAPTCHA, ensuring good performance, mobile responsiveness, and user experience. Security practices include HTTPS enforcement and anti-bot measures, though some security headers could be improved. Privacy and cookie policies are present and GDPR compliant, reflecting a mature approach to data protection. The security posture is solid with no critical vulnerabilities detected, but the absence of WHOIS data reduces transparency and slightly impacts trust. Overall, the site is reliable, professional, and trustworthy, serving its target audience effectively with a strong focus on healthcare and pharmaceutical innovation.

Scanned

NIS2 and GDPR posture

GDPR outside view
10/ 100 · Critical
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

11 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      EU business without adequate privacy measures

      EU businesses are subject to strict GDPR requirements

      What to do: Implement comprehensive GDPR compliance including privacy policy, cookie consent, and data protection measures

  2. Network security

    Services reachable from the internet are the first thing attackers probe. Anything open that does not need to be should be closed.

    • Critical

      Critical Service Exposed: MySQL

      Port 3306 (MySQL) is publicly accessible - MySQL - Database server

      What to do: Immediately restrict access to MySQL using firewall or VPN

      • NIS2 21(2)(e)
      • IR 2024/2690 6.7.2(f): Implementing Regulation (EU) 2024/2690, Annex point 6.7.2(f): Network security
      • NIST CM-7: NIST SP 800-53 Rev. 5 CM-7: Least Functionality
      • NIST SC-7: NIST SP 800-53 Rev. 5 SC-7: Boundary Protection

  3. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

Need hands-on remediation? Email guard@offseq.com

Keep watching badaniaklinicznewpolsce.pl

This scan found 28 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
62
Security headers
20
Email security
70
DNS health
75
Network security
0
GDPR outside view
10
Average
40

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet · found on this site
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention badaniaklinicznewpolsce.pl, from OffSeq Breach.

No leaked records found

Breach holds no records for badaniaklinicznewpolsce.pl right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.

Monitor on Breach (opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

INFARMA operates as an important industry association within the healthcare sector in Poland, advocating for innovative pharmaceutical companies. Its business model centers on collaboration, advocacy, education, and promotion of clinical research. The organization maintains partnerships with European and national industry bodies, enhancing its influence and credibility. Revenue streams likely include membership fees, event certifications, and educational initiatives. The target audience includes pharmaceutical companies, healthcare professionals, patients, and regulatory authorities. The website content and structure indicate a medium-sized organization with a stable market position and a focus on transparency and quality standards.

Security posture

The website demonstrates a good security maturity level with HTTPS enabled and use of Google reCAPTCHA to protect forms. No exposed sensitive data or vulnerable libraries were detected in the HTML content. However, some common security headers like Content-Security-Policy and X-Frame-Options are not explicitly present, which could enhance protection against clickjacking and content injection attacks. There is no public incident response or vulnerability disclosure information, which could be improved to increase transparency and readiness. Overall, the security posture is adequate for an industry association website but could benefit from additional hardening and published security policies.

Recommendations

  1. Implement and enforce security headers such as Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options to strengthen browser security.
  2. Publish a clear vulnerability disclosure policy or security.txt file to facilitate responsible reporting of security issues.
  3. Enhance incident response readiness by providing dedicated security contact channels.
  4. Regularly audit and update third-party libraries and scripts to mitigate emerging vulnerabilities.
  5. Maintain transparency by improving WHOIS data availability or providing official domain registration information.

Contact details published on the site

Addresses
Legal name
Związek Pracodawców Innowacyjnych Firm Farmaceutycznych INFARMA
VAT number
NIP 5213402914
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Związek Pracodawców Innowacyjnych Firm Farmaceutycznych INFARMA
Description
INFARMA is an employers' union representing innovative pharmaceutical companies in Poland, focusing on innovation, clinical trials, and advancing medical research and therapies.
Key services
Advocacy for clinical trials legislation, Educational and promotional campaigns, Collaboration with industry organizations POLCRO and GCPpl, Organizing conferences and awards, Providing information resources for patients and professionals
Content quality
good
Branding
consistent

Technology

Stack
Google Fonts, Bootstrap CSS, jQuery (implied by bootstrap usage), Google Analytics, Google Tag Manager, Google reCAPTCHA v3
Frameworks
Bootstrap
Performance
fast
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • Use of HTTPS
  • Use of Google reCAPTCHA for forms
  • No exposed sensitive data in HTML
  • No visible vulnerable libraries

Analytics and tracking

Services
Google Analytics, Google Tag Manager
Tracking level
moderate
Privacy practices
good

Advertising

Marketing tools
AddThis (ra-55ff63784d80d430)
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content about clinical trials and pharmaceutical innovation.
  2. No WAF or blocking mechanisms detected.
  3. WHOIS data is unavailable, which reduces transparency but does not alone indicate illegitimacy.
  4. Site uses HTTPS and modern web technologies.
  5. Contact information is clearly provided with company domain emails and phone numbers.
  6. Privacy and cookie policies are present and linked.
  7. No terms of service page found.
  8. Social media presence on LinkedIn, Twitter, Facebook, and YouTube.
  9. Content is in Polish with some English language options.
  10. Site is well-structured with clear navigation and relevant internal linking.
Technical notes

Notes

The website uses a modern and standard technology stack including Bootstrap for responsive design, Google Fonts for typography, and Google Analytics and Tag Manager for traffic analysis. The presence of Google reCAPTCHA v3 indicates attention to bot mitigation. The site loads quickly and is mobile optimized with clear navigation and SEO-friendly meta tags. No CMS is explicitly detected, suggesting a custom or proprietary solution. Hosting provider details are not available from the content. The technical implementation is solid with room for improvement in accessibility and security header implementation.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with badaniaklinicznewpolsce.pl. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review badaniaklinicznewpolsce.pl.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.